Stockreport

Erasca Shares Fall After Preliminary Phase 1 Dose Escalation Data [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF Erasca (ERAS) shares fell 48% Tuesday after the company reported preliminary phase 1 dose-escalation [Read more]